Memantine and reduced time with dyskinesia in Parkinson's Disease.

Research output: Contribution to journalArticle

Abstract

The partial glutamate antagonist amantadine is currently used in clinical practice, to reduce dyskinesia developing as a side-effect of levodopa treatment in patients suffering from Parkinson's disease (PD). This study was aimed at evaluating the antidyskinetic effect of another glutamate antagonist, memantine.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurology
Original languageEnglish
JournalActa Neurologica Scandinavica
Early online date2015 Aug 3
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes